Robexera is a non-steroidal anti-inflammatory drug (NSAID) in tablet form for oral administration, intended for pain relief and inflammation reduction in animals with musculoskeletal disorders and post-operative conditions. The active ingredient is robenacoxib, a selective COX-2 inhibitor with pronounced analgesic and anti-inflammatory effects.
Composition:
Each tablet contains:
- Robenacoxib – 5 mg, 10 mg, 20 mg, or 40 mg (depending on the dosage).
Indications for Use:
- Chronic musculoskeletal disorders (osteoarthritis).
- Pain and inflammation in the post-operative period.
Dosage and Administration:
The drug is intended for oral administration. Tablets should be given whole, without chewing, with or without food.
The recommended dose is 1–2 mg of robenacoxib per 1 kg of body weight once daily.
Example dosage:
| Body Weight (kg) | Dose (mg) | Number of Tablets |
|---|---|---|
| 2.5–5 | 5 | 1 tablet (5 mg) |
| 5–10 | 10 | 1 tablet (10 mg) |
| 10–20 | 20 | 1 tablet (20 mg) |
| 20–40 | 40 | 1 tablet (40 mg) |
| 40–80 | 80 | 2 tablets (40 mg) |
The duration of treatment is determined by the veterinarian. In chronic musculoskeletal conditions, the course may be prolonged.
Contraindications:
- Hypersensitivity to the components of the drug.
- Gastric and intestinal ulcers.
- Severe renal, hepatic, or cardiac insufficiency.
- Pregnancy and lactation.
- Puppies and kittens younger than 3 months.
Side Effects:
Gastrointestinal disorders (vomiting, diarrhea) may occur but usually resolve on their own. If serious adverse reactions develop, discontinue use and consult a veterinarian.
Before using Robexera, it is recommended to consult a veterinarian.
